Follow
hVIVO's Mo Khan on the company’s breakthrough year
25 January 2023 - 11:36
Vox Markets speaks to Mo Khan, chief executive of fast-growing clinical research specialist hVIVO, about the factors behind an expectation-beating year, and how rising awareness of its unique human challenge model points to major growth ahead....
We have reserved some of the more detailed information for our registered users. Please sign in if You have already registered.
Get access to Events, Instruments, Documents, Media and much more by signing up for FREE!
hVIVO Plc
hVIVO is a pharmaceutical service/contract research company that is a leader in testing vaccines and antivirals using human challenge clinical trials. The Company provides services to Big Pharma, biotech and government/public health organisations....
Learn more about company